This page provides an independent statistical analysis and educational interpretation of publicly reported results. ClinicalTrials.gov provides the official trial registry record.
1. Trial at a Glance
ADMIRAL was a clinical study evaluating AlloSure monitoring insights of renal allografts with longitudinal surveillance in the setting of kidney transplant rejection.
| Feature | ADMIRAL |
|---|---|
| ClinicalTrials.gov identifier | NCT04566055 |
| Status | UNKNOWN |
| Condition | Kidney Transplant Rejection |
| Lead sponsor | CareDx |
| Sponsor type | INDUSTRY |
| Intervention | AlloSure (device) |
2. Clinical Question
Population
Patients represented in a longitudinal surveillance study of renal allografts.
Intervention
AlloSure device monitoring.
Comparator
The registry describes one study arm.
Primary question
Validation of AlloSure in allograft rejection.
3. Trial Design
Enrollment
1000 participants
Monitoring
AlloSure device
Surveillance
Longitudinal follow-up
Endpoint
October 2020
Single-arm clinical study.
Assessment of AlloSure in allograft rejection.
4. Primary Endpoint
| Endpoint | Time frame |
|---|---|
| Validation of AlloSure in Allograft rejection | October 2020 |
5. Planned Analysis
The registry identifies validation of AlloSure in allograft rejection as the primary endpoint. Results have not been posted on ClinicalTrials.gov.
For a validation endpoint involving a diagnostic or monitoring device, statistical evaluation commonly focuses on the relationship between the device measurement and evidence of the clinical condition being evaluated. Depending on the prespecified analysis plan, this type of study may involve measures of diagnostic performance, agreement, discrimination, or association with rejection outcomes.
A validation study differs from a randomized treatment comparison. The primary statistical question is generally whether a measurement method provides reliable information for identifying or monitoring a clinical state rather than whether one intervention improves outcomes compared with another.
6. Statistical Methodology
Validation study framework
Validation studies require a clearly defined clinical reference standard and prespecified criteria for determining how well a measurement performs. Important considerations include the population evaluated, timing of measurements, missing observations, and the relationship between device readings and clinical outcomes.
Single-arm analysis
Because the registry describes one study arm, the interpretation focuses on characterization and validation of AlloSure monitoring rather than a randomized between-group treatment effect.
Uncertainty in statistical estimates
Any estimated diagnostic or predictive performance measure should be interpreted together with uncertainty measures such as confidence intervals. A point estimate alone does not describe the precision of the finding.
7. Statistical Methods Explained
How is a monitoring device validated?
Validation generally evaluates whether measurements from the device correspond to clinically meaningful states. The statistical approach depends on the endpoint definition and reference method.
Why does a single-arm design matter?
Without a randomized comparator group, the study is not designed to estimate a treatment effect between two assigned interventions. Instead, it evaluates performance or association within the studied population.
Why are confidence intervals important?
Confidence intervals describe uncertainty around an estimate. A narrow interval suggests greater precision, while a wide interval indicates more uncertainty.
Why does endpoint definition matter?
The statistical interpretation depends on exactly how rejection and monitoring performance are defined. Different endpoint definitions answer different clinical questions.
Why can missing data affect validation studies?
Incomplete measurements or unavailable reference assessments can influence estimates and should be addressed according to a prespecified analysis plan.
8. Limitations
- No posted results: The registry does not report statistical results for the primary endpoint.
- Single-arm design: The design does not provide a randomized comparison between treatment strategies.
- Endpoint interpretation: Validation conclusions depend on the detailed endpoint definitions and analysis methods.
- Registry completeness: Public registry information may not include the full statistical analysis plan.
9. Why This Trial Matters Statistically
ADMIRAL illustrates important concepts in clinical measurement research and statistical validation.
| Concept | Application |
|---|---|
| Validation analysis | Evaluating whether a monitoring approach provides clinically useful information. |
| Single-arm design | Focuses on characterization rather than randomized treatment comparison. |
| Endpoint definition | Determines the exact statistical question being answered. |
| Confidence intervals | Describe uncertainty around estimates. |
10. Sources
- ClinicalTrials.gov: NCT04566055